Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

• Mengshi Zhou,

  Roles Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, United States of America

  http://orcid.org/0000-0002-0081-2485

  ⨯
• Rong Xu ,

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: rxx@case.edu (R.X.); mark@tetratherapeutics.com (M.E.G.)

  Affiliation Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, United States of America

  ⨯
• David C. Kaelber,

  Roles Conceptualization, Writing – review & editing

  Affiliations Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, United States of America, Departments of Internal Medicine and Pediatrics and the Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, OH, United States of America

  ⨯
• Mark E. Gurney

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: rxx@case.edu (R.X.); mark@tetratherapeutics.com (M.E.G.)

  Affiliation Tetra Therapeutics, Grand Rapids, MI, United States of America

  ⨯